Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPN1 | P15169 | 1/20 | 0.32 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.31 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.30 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.30 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL3783919 | 0.88 | CPN1 (0.33) | CPN1CPB2ITGB3ITGA2BCHRM3 | |
| SCHEMBL3780326 | 0.81 | TPSAB1 (0.31) | CPN1CPB2TPSAB1TPSD1TPSG1 | |
| Trifluoroacetic Acid SCHEMBL3784593 | 0.79 | SLC6A2 (0.32) | — | |
| Trifluoroacetic Acid SCHEMBL3783935 | 0.77 | CPB2 (0.41) | CPB2 | |
| Trifluoroacetic Acid SCHEMBL3782819 | 0.77 | CPB2 (0.41) | CPB2 | |
| Trifluoroacetic Acid SCHEMBL3781605 | 0.77 | CPB2 (0.41) | CPB2 | |
| Trifluoroacetic Acid SCHEMBL3780429 | 0.76 | CPB2 (0.46) | CPB2 | |
| Trifluoroacetic Acid SCHEMBL3787528 | 0.75 | CPB2 (0.48) | CPB2CHRM3 | |
| Trifluoroacetic Acid SCHEMBL3776202 | 0.74 | HTR5A (0.31) | CPB2 | |
| Trifluoroacetic Acid SCHEMBL3782480 | 0.74 | CPB2 (0.30) | CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8309341-B2 | 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them | Les Laboratories Server (FR) | 2012-11-13 | — | — | US | disclosed |
| US-20100330064-A1 | 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100330064-A1 | 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them | CYP2B6, CYP2A6, MC5R | CPN1 1883/4885CPB2 1603/4885ITGB3 1439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.